First human test of stem cells to combat frailty in aging
Disease control
Not yet recruiting
This is a very early-stage study to check if a new stem cell therapy is safe for older adults with mild to moderate frailty. About 12 participants will receive either the stem cell infusion or a placebo, and researchers will closely monitor them for side effects. The main goal is…
Phase: PHASE1 • Sponsor: Ji Yan Biomedical Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC